Carol Spieckerman’s Retail Insights
Glp-1 Meds a Shift, Not a Shock to Retail
Carol Spieckerman Speaks with the Daily Mail on the real impact of GLP-1 drugs on retailers and suppliers and why choice is king regardless.
Is Nothing Off-Limits for Aldi Knockoffs?
Carol Spieckerman speaks with the Daily Mail about why Aldi’s Girl Scout cookie dupes are nothing new, if if they wear some brands thin.
Sukoshi Coming in Hot as Beauty Beast
Carol Spieckerman speaks with the Daily Mail on why Canadian Asian beauty disruptor, Sukoshi has real staying power.
Saks Bankruptcy Speaks to Systemic Problems
Carol Spieckerman speaks with the Daily Mail on Saks’ post-bankruptcy prospects and who will benefit from it.
Temu and Shein Caught in Trump Tariff Trap
Carol Spieckerman speaks with the Daily Mail about how tariffs are slowing Temu and Shein’s rolls and giving competitors a chance to catch up.